Budi Riyanto Wreksoatmodjo
Departemen Ilmu Penyakit Saraf, Fakultas Kedokteran Dan Ilmu Kesehatan, Universitas Katolik Indonesia Atma Jaya, Jakarta, Indonesia

Published : 70 Documents Claim Missing Document
Claim Missing Document
Check
Articles

HUBUNGAN ANEMIA DENGAN TINGKAT KEPARAHAN DAN PERJALANAN PENYAKIT STROKE ISKEMIK AKUT Eugenia Isadora; Budi Riyanto Wreksoatmodjo; Tara Puspitarini Sani
NEURONA Vol 38 No 3 (2021)
Publisher : PERDOSNI

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Introduction: Stroke is the second leading cause of death and the third leading cause of disability throughout theworld. Anemia or reduced hemoglobin level can worsen the tissue damage caused by ischemia; including ischemic braintissue caused by ischemic stroke. Aim: This research aims to determine the association between anemia and stroke severity and clinical course basedon the NIHSS score among acute ischemic stroke patients in Atma Jaya Hospital during 2014-2019 Methods: A cross-sectional study using secondary data from Atma Jaya Stroke Registry from 2014-2019. A totalsampling method obtained 347 samples with complete pertinent data. Anemia was defined as Hb level <12 g/dL for womenand <13 g/dL for men. Stroke severity was measured by NIHSS score. Association between variables was calculated withthe chi-square test. Results: The risk factor associated with the severity of stroke was hypertension (p=0.013). There was no significantassociation between anemia and stroke severity on admission (p=0.895) and hospital discharge (p=0.773). There was nosignificant association between anemia and the clinical course of acute ischemic stroke (p=0.09). Discussion: Factors that may contribute to the various results of similar studies were differences in study design,anemia as a comorbid condition, genetic factors, sample size, and differences in measurement methods of stroke outcomeor severity. Keywords: Anemia, ischemic stroke, NIHSS, severity
HUBUNGAN TINGKAT KETERGANTUNGAN DAN TINGKAT STRES PASIEN STROKE AKUT RAWAT INAP Daniella Natasya; Budi Riyanto Wreksoatmodjo; Mahaputra Mahaputra
NEURONA Vol 38 No 4 (2021)
Publisher : PERDOSNI

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Introduction: Stroke is the second leading cause of death worldwide and the leading cause of disability in adults. Disability will affect functional abilities in activities of daily living which can lead to mental health issues, for example, psychological stress. Aim: This study aims to determine the relationship between the level of dependence and the level of stress in hospitalized acute stroke patients Methods: A cross-sectional analytic study was conducted on 64 respondents of acute stroke patients hospitalized at Atma Jaya Hospital and Izza Hospital from November 2020-March 2021. The level of ADL dependence was determinedusing the Barthel Index questionnaire, and the stress level was determined using the DASS-42 questionnaire. Data analysis using Chi-square test with alternative Kruskal Wallis test. Results: Most respondents were male (59.4%) and aged ≥ 59 years (62.5%). The majority have a moderate level of dependence (42.2%) and experience moderate stress (39.1%). There is a relationship between the level of dependence and the stress level with a p<0.05. Discussion: Limitations in daily activities caused by a stroke can cause stress. Untreated, prolonged stress can lead to more serious mental health disorders. Families and nurses need to carry out psychological management to improve the quality of life of stroke survivors. Keywords: Acute stroke, ADL, dependency level, stress level
FAKTOR –FAKTOR YANG BERHUBUNGAN DENGAN LAMA PERAWATAN RAWAT INAP PASIEN STROKE DI RUMAH SAKIT ATMA JAYA Kezia Nathania Limbong Allo; Budi Riyanto Wreksoatmodjo; Poppy Sasmita
NEURONA Vol 39 No 1 (2021)
Publisher : PERDOSNI

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52386/neurona.v39i1.284

Abstract

ABSTRACT Introduction:Stroke patients require a comprehensive treatment at the hospital. At the other hand, length of hospitalization is related to the cost of health care and risk of complication. By understanding more about the contributing factors of length of hospitalization, stroke units candevelop better interventions to reduce prolonged hospitalization and toprevent complications during hospital stay. Aims:This study aims to determine the association between demographic characteristics, comorbidities, complications, type of stroke, severity of stroke, and level of consciousness with length of hospitalization among stroke patients in Atma Jaya Hospital. Method:This cross-sectional study was performed on 254 eligible stroke patients in Atma Jaya Hospital during 2014-2019. Assessment of variables based on secondary data from stroke registry.. Prolonged hospitalization was defined as >7 days. Data analysis was performed using Fisher-exact test, Breslow-Day test, Mantel-Haenzel test, and logistic regression test. Result: From a total of 254 respondents, 65 (25.6%) have a prolonged length of hospitalization. Analysis showed that complications, type of stroke, severity of stroke and level consciousness had a significant association with length of hospitalization. The most influential risk factor on prolonged hospitalization was type of stroke, complication and severity of stroke,. Conclusion: There is a significant relationship between complications, type of stroke, severity of stroke, and level of consciousness with length of hospitalization. Hemorrhagic stroke, patient with severe stroke and complication are the dominant factors for prolonged length of hospitalization in stroke patient.
Anosmia pada COVID-19 Ishak Samuel; Budi Riyanto Wreksoatmodjo
Cermin Dunia Kedokteran Vol 48 No 1 (2021): Infeksi COVID-19
Publisher : PT Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v48i1.30

Abstract

Sejak tanggal 11 Maret 2020, WHO telah mendeklarasikan COVID-19 sebagai pandemi. Gejala COVID-19 yang paling umum adalah demam, malaise, dan batuk kering, namun dapat juga muncul gejala gangguan penghidu atau anosmia. Anosmia pada COVID-19 dapat disebabkan oleh invasi langsung oleh virus melalui epitel hidung dan bulbus olfaktorius pada reseptor ACE2. Anosmia pada COVID-19 ini dapat timbul tiba-tiba atau didahului oleh gejala ringan seperti batuk kering. Tatalaksana anosmia pada COVID-19 masih terus berkembang dan diteliti lebih lanjut. Since March 11, 2020, WHO has declared COVID-19 a pandemic. The most common symptoms of COVID-19 are fever, malaise, and dry cough, but there can also be symptoms of olfactory dysfunctions including anosmia. Anosmia in COVID-19 can be caused by direct viral invasion through the nasal epithelium and olfactory bulb at the ACE2 receptor. Anosmia in COVID-19 can spontaneously appear or preceded by mild symptoms such as dry cough. The management of anosmia in COVID-19 is still developing and needs more in-depth research.
Pengaruh Coronavirus Disease 2019 (COVID-19) terhadap Insidens dan Tatalaksana Penyakit Serebrovaskular Billy Priyanto Hamidjoyo; Budi Riyanto Wreksoatmodjo
Cermin Dunia Kedokteran Vol 48 No 8 (2021): Continuing Medical Education - Edisi 3
Publisher : PT Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v48i8.109

Abstract

COVID-19 dikenal dengan manifestasi klinis terkait saluran pernapasan seperti batuk, sesak, dan demam. Namun, saat ini telah banyak diteliti bahwa COVID-19 dapat menimbulkan gejala di luar sistem pernapasan, salah satunya ke sistem saraf. Pelaporan kejadian stroke pada pasien COVID-19 masih bervariasi, namun pada pasien COVID-19, khususnya yang bergejala berat terdapat kondisi hiperkoagulasi yang dapat menyebabkan komplikasi trombotik seperti trombosis vena dalam dan diduga berkaitan dengan risiko stroke pada pasien COVID-19. COVID-19 is known for its clinical manifestations related to the respiratory tract such as cough, shortness of breath, and fever. However, currently it has been widely studied that COVID-19 can cause symptoms outside the respiratory system, one of which is the nervous system. Reports of stroke events in COVID-19 patients still vary, but in COVID-19 patients, especially those with severe symptoms, there is a hypercoagulable condition that can cause thrombotic complications such as deep vein thrombosis and is thought to be associated with the risk of stroke in COVID-19 patients.
Komplikasi Sistem Saraf Pusat pada COVID-19 Tasia Esterita; Budi Riyanto Wreksoatmodjo
Cermin Dunia Kedokteran Vol 48 No 11 (2021): Penyakit Dalam - COVID-19
Publisher : PT Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v48i11.144

Abstract

Coronavirus disease-19 disebabkan oleh virus SARS-CoV-2 yang menyebabkan pandemi sejak Maret 2020. COVID-19 tidak hanya menyebabkan komplikasi pernapasan dan kardiovaskular, tetapi dapat menyebabkan komplikasi sistem saraf pusat yang juga berkontribusi terhadap mortalitas dan morbiditas. Beberapa komplikasi sistem saraf pusat pada COVID-19 adalah stroke iskemik, stroke hemoragik, meningoensefalitis, acute transverse myelitis, dan ensefalopati. Stroke iskemik pada COVID-19 disebabkan oleh beberapa mekanisme, di antaranya koagulopati, disfungsi endotel, kardioemboli, invasi virus ke sistem saraf pusat, dan terapi imunoglobulin. Stroke hemoragik dapat disebabkan oleh kerusakan endotel akibat inflamasi menyebabkan disregulasi tekanan darah yang meningkatkan risiko stroke hemoragik. Meningoensefalitis pada COVID-19 disebabkan invasi virus langsung melalui cribriform plate atau karena kerusakan endotel yang menjadi pintu masuk SARS-CoV-2 ke otak. Mielitis transversa pada COVID-19 disebabkan hiperinflamasi sistemik, molecular mimicry, dan epitope spreading. Kegagalan organ multipel pada pasien COVID-19 akibat badai sitokin dapat menyebabkan ensefalopati. Coronavirus disease-19 is caused by the SARS-CoV-2 virus that has been causing a pandemic since March 2020. Besides respiratory and cardiovascular complications, COVID-19 can cause complications to central nervous system that also contribute to mortality and morbidity. Some central nervous system complications in COVID-19 are ischemic stroke, hemorrhagic stroke, meningoencephalitis, acute transverse myelitis, and encephalopathy. Ischemic stroke in COVID-19 is caused by several mechanisms, including coagulopathy, endothelial dysfunction, cardioembolism, viral invasion of the central nervous system and immunoglobulin therapy. Hemorrhagic stroke can be associated with blood pressure dysregulation caused by inflammational endothelial damage. Meningoencephalitis in COVID-19 can be caused by direct viral invasion through the cribriform plate or due to endothelial damage that facilitate SARS-CoV-2 entrance to the brain. Transverse myelitis in COVID-19 is caused by systemic hyperinflammation, molecular mimicry and epitope spreading. Multiple organ failure in COVID-19 patients due to a cytokine storm can lead to encephalopathy.
Pengaruh Coronavirus Disease 2019 (COVID-19) terhadap Fungsi Kognitif Vidya Gani Wijaya; Budi Riyanto Wreksoatmodjo
Cermin Dunia Kedokteran Vol 49 No 2 (2022): Infeksi
Publisher : PT Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v49i2.196

Abstract

Pasien COVID-19 memiliki gejala bervariasi. Saat ini, selain ditemukan gejala pada sistem pernapasan dan pencernaan, gejala di sistem organ lain pun mulai banyak ditemukan, salah satunya pada sistem saraf dengan gejala neurologis yang bervariasi seperti anosmia (sering), stroke, nyeri kepala, kejang, dan penurunan fungsi kognitif. Tata laksana pasien dengan penurunan fungsi kognitif masih diteliti. Beberapa pilihan terapi di antaranya human recombinant erythropoietin, flavonoid, dan terapi imun (IVIg) yang masih kontroversial. COVID-19 patients have varied symptoms. At present, in addition to symptoms in the respiratory and digestive systems, symptoms in other organ systems have begun to be found, one of which is in the nervous system with various neurological symptoms such as anosmia (frequent), stroke, headaches, seizures, and decreased cognitive function. Management of patients with decreased cognitive function is still being studied. Several therapeutic options include human recombinant erythropoietin, flavonoids, and immune therapy (IVIg), which are still controversial.
Fatigue sebagai Gejala Sisa COVID-19 Brigitta Gladiola; Budi Riyanto Wreksoatmodjo
Cermin Dunia Kedokteran Vol 49 No 4 (2022): Penyakit Dalam
Publisher : PT Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v49i4.216

Abstract

COVID-19 merupakan penyakit akibat infeksi Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2). Dewasa ini, makin banyak penelitian menunjukkan adanya gejala menetap pasca-infeksi COVID-19. Prevalensi pasien pasca-COVID-19 yang memiliki gejala fatigue pada 1-3 bulan pasca-infeksi mencapai 52-70%. Beberapa teori mekanisme fatigue pasca-infeksi COVID-19 antara lain teori disfungsi hipotalamus dan teori GABA. Tata laksana pasien pasca-infeksi COVID-19 dengan gejala fatigue masih perlu diteliti lebih lanjut. Beberapa anjuran intervensi yaitu berolahraga, terapi mindfulness, latihan pernapasan, serta peregangan tubuh/stretching. Sampai saat ini, belum ada tata laksana berbasis bukti ilmiah untuk mengatasi gejala fatigue pasca-infeksi COVID-19. COVID-19 is an infection caused by Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2). There is an increasing data on the clinical manifestations of post COVID-19. Around 52-70% individuals recovering from COVID-19 complains of fatigue. Two leading theories of its mechanisms include hypothalamus dysfunction theory and GABA theory. More studies are needed to fully understand the mechanism of post COVID-19 fatigue. There is no specific treatment available, but some interventions such as exercise, mindfulness therapy, and body stretching can be used to ease post COVID-19 fatigue.
Kaitan COVID-19 dengan Risiko Bangkitan Epileptik Stephanie Johanes; Budi Riyanto Wreksoatmodjo
Cermin Dunia Kedokteran Vol 49 No 5 (2022): Neuro-Kardiovaskular
Publisher : PT Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v49i5.228

Abstract

COVID-19 dapat menyebabkan kegagalan organ tubuh seperti sistem pernapasan, ginjal, hati, dan jantung. Pada beberapa orang juga ditemukan gejala sistem saraf, seperti delirium, confusion, nyeri kepala, vertigo, hemorrhagic stroke dan iskemik, hilangnya sensasi penciuman dan perasa, kejang atau bangkitan epileptik. Bangkitan epileptik pada kasus COVID-19 dapat dikaitkan dengan aktivasi sel glia, kerusakan sawar darah-otak, keadaan hipertermia atau gangguan elektrolit dan gangguan neurotransmiter. Di lain pihak, pengaruh infeksi COVID-19 pada pasien epilepsi masih belum diketahui pasti. COVID-19 can cause organ failure such as the respiratory system, kidneys, liver, and heart. Risks of neurological complications are delirium, stroke, loss of smell dan taste, and convulsion/epileptic seizure. Seizures in COVID-19 may be associated with glial activation, blood-brain barrier disruption, and hyperthermia and/ or neurotransmitter dysregulation. On the other hand, the impact of COVID-19 on epileptic patients is yet to be identified
Sindrom Guillain-Barre sebagai Gejala COVID-19 dan Potensi Efek Samping Pasca-Vaksinasi COVID-19 Joanesa Della Felista; Budi Riyanto Wreksoatmodjo
Cermin Dunia Kedokteran Vol 49 No 9 (2022): Neurologi
Publisher : PT Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v49i9.295

Abstract

COVID-19 adalah penyakit infeksi virus SARS-CoV-2. Gejala umum COVID-19 adalah pada saluran pernapasan, namun dapat ditemukan gejala neurologis antara lain sindrom Guillain-Barré (GBS). Hingga saat ini prevalensi kasus GBS pada pasien COVID-19 sekitar 0,15%. Selain itu, GBS juga dapat merupakan salah satu efek samping setelah pemberian vaksin COVID-19. Insiden GBS lebih banyak pada penerima vaksin viral vector (0,38/100.000 dosis) dibandingkan penerima vaksin mRNA (0,18/100.000 dosis). Hingga saat ini belum ada laporan kasus GBS pasca-vaksinasi berbasis protein. Hampir semua kasus GBS baik yang menerima vaksin berbasis mRNA maupun viral vector menunjukkan respons baik terhadap terapi IVIg.   COVID 19 is primarily a respiratory viral infection, but there are reports of neurological symptoms among patients; one of the accompanying neurological symptoms is Guillain-Barré Syndrome (GBS). Its prevalence among COVID 19 patients is approximately 0.15%. GBS is also reported as a side effect after COVID vaccinations. Its incidence in greater among viral vector vaccine recipients (0.38/100.000 doses) as compared to mRNA vaccine recipients (0.18/ 100.000 doses). No GBS case was reported after protein-based vaccine administration. The majority of cases responded well after IVIg therapy.